LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced that its management is scheduled to participate in the following upcoming investor conferences:
9th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference
Date: August 12, 2024
Canaccord Genuity 44th Annual Growth Conference
Presentation: August 13, 2024 at 10:00am
A live webcast of the presentation will be accessible through the “Investors” section of the Company’s website at www.angiodynamics.com.
About AngioDynamics, Inc.
AngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients.
The Company’s innovative technologies and devices are chosen by talented physicians in fast-growing healthcare markets to treat unmet patient needs. For more information, visit www.angiodynamics.com.
Contacts
Investors:
AngioDynamics, Inc.
Stephen Trowbridge, Executive Vice President & CFO
(518) 795-1408
Top-line data anticipated in early Q3 2025. BOSTON--(BUSINESS WIRE)--Sensory Cloud Inc., a health technology company…
Top-line data anticipated in early Q3 2025. BOSTON--(BUSINESS WIRE)--Sensory Cloud Inc., a health technology company…
The Summit will bring together supply chain, commercial, finance, IT, and procurement leaders to explore…
Medical Advisory Board additions support company’s growing product offerings across women’s health and family building…
SAN JOSE, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”),…
– Expect to report topline data from the Seabreeze STAT COPD study in 1H 2026…
![](data:image/svg+xml;charset=utf-8,<svg height="32px" width="32px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
